Insights On Partnering

1. Discover The Path To Oncology Success 8/22/2025

   The oncology landscape is brimming with innovative therapies and new treatment approaches. Successful commercialization requires a well-orchestrated strategy to bring these complex products to market.

2. Advancing Oncology Innovation With Adaptive Trial Designs 8/12/2025

   When a biopharmaceutical company developing a novel therapy for solid tumor cancers became concerned with rapid over-enrollment from within a single region, they employed a CRO for assistance.

3. Bringing Clinical Trials To Everyone's Backyard 1/10/2025

   Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.

4. eCOA Solution Design Recommendations: Applied Insights From Trial Sites, CRAs 6/17/2024

   Enhance hybrid trials with digitalization through remote data capture using smartphones, tablets, and computers, improving participant experience and data integrity.

5. Single IRB Review: Tips For Sponsors And CROs Working With Institutional Sites 11/7/2024

   Develop an understanding of the institutional IRB’s role and explore how sponsors and CROs can address the potential impact of mandated sIRB oversight and pave the way for smoother implementation.

6. Advancing Your API To First Human Dose Trials More Efficiently 2/7/2024

   Learn how end-to-end support for development and manufacturing, clinical trial services, advanced drug delivery, and commercial packaging can accelerate drug development and time to market.

7. Why The Regional Site Manager Is The Swiss Army Knife Of Clinical Trial Monitoring 1/28/2025

   The Regional Site Manager (RSM) monitoring model eliminates numerous clinical trial risks by leveraging efficient, start-to-finish site management by a single, expert point of contact.

8. Pursuing Breakthrough Therapies For Rare Metabolic Diseases 2/14/2024

   Explore how a comprehensive clinical trial team expertly coordinated the dosing administration and data review for gene therapy, ensuring meticulous management and streamlined processes.

9. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

   Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

10. Biometric Services For Large Pharmaceutical Company 7/31/2025

    This case exemplifies the effectiveness of flexible staffing solutions in meeting the dynamic needs of the biopharmaceutical industry while maintaining control over project deliverables and timelines.